Weiss Multi-Strategy Advisers’s Vanda Pharmaceuticals VNDA Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-20,000	Closed	-$328K	–	633
2019 Q4	$328K	Sell	20,000 -30,000	-60%	-$454K	0.01%	558
2019 Q3	$664K	Sell	50,000 -30,000	-38%	-$418K	0.01%	474
2019 Q2	$1.13M	Sell	80,000 -5,000	-6%	-$79.6K	0.03%	369
2019 Q1	$1.56M	Buy	85,000 +9,000	+12%	+$205K	0.04%	357
2018 Q4	$1.99M	Buy	76,000 +36,000	+90%	+$846K	0.08%	227
2018 Q3	$918K	Buy	40,000 +642	+2%	+$13.1K	0.02%	405
2018 Q2	$750K	Sell	39,358 -642	-2%	-$10.7K	0.02%	466
2018 Q1	$674K	Sell	40,000 -10,000	-20%	-$167K	0.02%	451
2017 Q4	$760K	Sell	50,000 -5,000	-9%	-$74.2K	0.02%	466
2017 Q3	$985K	Sell	55,000 -3,000	-5%	-$50.2K	0.04%	377
2017 Q2	$945K	Sell	58,000 -2,000	-3%	-$28.8K	0.04%	368
2017 Q1	$840K	Buy	60,000 +10,000	+20%	+$143K	0.03%	409
2016 Q4	$798K	Buy	50,000 +38,000	+317%	+$611K	0.04%	294
2016 Q3	$200K	Buy	+12,000	New	+$162K	0.01%	398
2016 Q2	–	Sell	-10,000	Closed	-$84K	–	507
2016 Q1	$84K	Sell	10,000 -2,500	-20%	-$20.5K	﹤0.01%	448
2015 Q4	$116K	Hold	12,500	–	–	0.01%	363
2015 Q3	$141K	Sell	12,500 -7,500	-38%	-$91.7K	0.01%	373
2015 Q2	$254K	Sell	20,000 -26,400	-57%	-$285K	0.01%	410
2015 Q1	$432K	Sell	46,400 -3,600	-7%	-$40.7K	0.02%	379
2014 Q4	$716K	Sell	50,000 -15,000	-23%	-$177K	0.02%	309
2014 Q3	$675K	Sell	65,000 -10,000	-13%	-$131K	0.02%	420
2014 Q2	$1.21M	Buy	75,000 +26,640	+55%	+$355K	0.03%	395
2014 Q1	$786K	Sell	48,360 -1,640	-3%	-$23.3K	0.02%	548
2013 Q4	$621K	Buy	50,000 +10,000	+25%	+$100K	0.01%	562
2013 Q3	$438K	Sell	40,000 -40,000	-50%	-$427K	0.01%	567
2013 Q2	$646K	Buy	+80,000	New	+$539K	0.02%	435

Other funds holding VNDA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Weiss Multi-Strategy Advisers's VNDA Position: Q1 2020 in Review

Weiss Multi-Strategy Advisers sold out of Vanda Pharmaceuticals (VNDA) in Q1 2020, closing a stake of 20,000 shares — an estimated $328K sold.

Weiss Multi-Strategy Advisers first reported a position in VNDA in Q2 2013 and held it in 26 quarters. The position peaked at $1.99M in Q4 2018. 159 funds tracked by Wall St. Rank hold VNDA as of Q1 2020.

Weiss Multi-Strategy Advisers reported no remaining Vanda Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 20,000 Vanda Pharmaceuticals shares in Q1 2020, an estimated $328K.
Weiss Multi-Strategy Advisers first reported a position in Vanda Pharmaceuticals in Q2 2013 and held it in 26 quarters.
Weiss Multi-Strategy Advisers's Vanda Pharmaceuticals position peaked at $1.99M in Q4 2018.
159 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2020.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2020, filed 15 May 2020.